Defibrillators Market to Reach over USD 17.7 Bn by 2022, States KBV Research in Its New Topical Report Published at MarketPublishers.com
21 Nov 2016 • by Natalie Aster
LONDON – The global defibrillators marketplace is poised to reach, in value terms, close to USD 17.799 billion by 2022-end. The transvenous implantable cardioverter defibrillator (T-ICD) sector holds the greatest potential among implantable cardioverter defibrillators, mainly owing to highly targeted functioning and precision provided.
Biotronik SE & Co. KG, LivaNova PLC, Asahi Kasei Corporation, Philips Healthcare, Nihon Kohden Corporation, Stryker Corporation, Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, and Cardiac Science Corporation are the leading players engaged in the worldwide defibrillators marketplace.
Topical research study “Global Defibrillators Market” elaborated by KBV Research presents an all-round, trustworthy examination of the market for defibrillators on a worldwide scale, segmented by product, end-use sector, and geographic region. The report sheds light on the adoption of defibrillators from pole to pole. It provides a detailed assessment of the market size, scrutinises the forcers shaping the development of the marketplace. The research publication gives insights into the competitive scene and offers detailed profiles of the top 10 market players limelighting a company overview, financial data analysis, segment-wise analysis, and R&D expenses, among others. Additionally, the research report presents detailed forecasts of the defibrillators market through to 2022.
Other market research publications by KBV Research can be found at its page.